Asthma - Versorgungsleitlinien.de

NVL Asthma, 2. Auflage
Langfassung
Juli 2011, Version 1.3
314. Kuna P, Peters MJ, Manjra AI, Jorup C, Naya IP, Martinez-Jimenez NE, Buhl R. Effect of
budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J
Clin Pract 2007;61(5):725-36.
315. Joos S, Miksch A, Szecsenyi J, Wieseler B, Grouven U, Kaiser T, Schneider A. Montelukast as
add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a
systematic review. Thorax 2008;63(5):453-62.
316. Price DB, Hernandez D, Magyar P, Fiterman J, Beeh KM, James IG, Konstantopoulos S, Rojas
R, van Noord JA, Pons M, Gilles L, Leff JA. Randomised controlled trial of montelukast plus
inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma.
Thorax 2003;58(3):211-6.
317. Evans DJ, Taylor DA, Zetterstrom O, Chung KF, O'Connor BJ, Barnes PJ. A comparison of lowdose
inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate
asthma. N Engl J Med 1997;337(20):1412-8.
318. Ukena D, Harnest U, Sakalauskas R, Magyar P, Vetter N, Steffen H, Leichtl S, Rathgeb F, Keller
A, Steinijans VW. Comparison of addition of theophylline to inhaled steroid with doubling of
the dose of inhaled steroid in asthma. Eur Respir J 1997;10(12):2754-60.
319. Gemeinsamer Bundesausschuss (G-BA). Beschluss des Gemeinsamen Bundesausschusses
über eine Änderung der Arzneimittel-Richtlinie in Anlage 4: Therapiehinweis zu Montelukast
vom 15. November 2007. Dtsch Arztebl 2008;105(18):A-966-8.
320. Lemanske RF, Jr., Mauger DT, Sorkness CA, Jackson DJ, Boehmer SJ, Martinez FD, Strunk
RC, Szefler SJ, Zeiger RS, Bacharier LB, Covar RA, Guilbert TW, Larsen G, Morgan WJ,
Moss MH, Spahn JD, Taussig LM. Step-up therapy for children with uncontrolled asthma
receiving inhaled corticosteroids. N Engl J Med 2010;362(11):975-85.
321. Sorkness CA, Lemanske RF, Jr., Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, Strunk
RC, Szefler SJ, Zeiger RS, Bacharier LB, Bloomberg GR, Covar RA, Guilbert TW, Heldt G,
Larsen G, Mellon MH, Morgan WJ, Moss MH, Spahn JD, Taussig LM. Long-term
comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the
Pediatric Asthma Controller Trial. J Allergy Clin Immunol 2007;119(1):64-72.
322. Stelmach I, Grzelewski T, Bobrowska-Korzeniowska M, Stelmach P, Kuna P. A randomized,
double-blind trial of the effect of anti-asthma treatment on lung function in children with
asthma. Pulm Pharmacol Ther 2007;20(6):691-700.
323. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K,
Tattersfield A. Low dose inhaled budesonide and formoterol in mild persistent asthma: the
OPTIMA randomized trial. Am J Respir Crit Care Med 2001;164(8 Pt 1):1392-7.
324. Miraglia del GM, Piacentini GL, Capasso M, Capristo C, Maiello N, Boner AL, Capristo AF.
Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and
exhaled nitric oxide. Respir Med 2007;101(8):1809-13.
325. Peters SP, Anthonisen N, Castro M, Holbrook JT, Irvin CG, Smith LJ, Wise RA. Randomized
comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med
2007;356(20):2027-39.
326. Stempel DA, Riedel AA, Carranza R, Jr. Resource utilization with fluticasone propionate and
salmeterol in a single inhaler compared with other controller therapies in children with
asthma. Curr Med Res Opin 2006;22(3):463-70.
Gilt nur für
Erwachsene
Gilt nur für
Kinder/Jugendliche
Allgemeine
Empfehlungen
© 2009 223